<DOC>
	<DOCNO>NCT02656160</DOCNO>
	<brief_summary>In protocol investigator test effect dalfampridine ( potassium channel blocker ) genioglossus muscle activity ( EMG GG ) wakefulness sleep healthy control subject .</brief_summary>
	<brief_title>Effect Dalfampridine ( 4-AP ) Genioglossus Muscle Activity Healthy Adults</brief_title>
	<detailed_description>Two overnight sleep study , placebo night drug night , perform approximately one week apart random order . The placebo drug administer 3 hour light . At least 10 minute quiet wakefulness record quantify subject 's awake EMG GG activity administration placebo/dalfampridine . EMG GG activity measure 10 min lights stable NREM REM sleep ( free arousal artifact ) . During second part night , subject connect modified continuous positive airway pressure ( CPAP ) machine ( Pcrit3000 , Respironics ) provide wide range pressure 20 -20 cmH2O order modify upper airway pressure measure change EMG GG function epiglottic pressure ( muscle responsiveness ) .</detailed_description>
	<mesh_term>Sleep Apnea , Obstructive</mesh_term>
	<mesh_term>4-Aminopyridine</mesh_term>
	<criteria>Healthy control subject Cardiovascular disease well control hypertension History seizure</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>July 2016</verification_date>
</DOC>